dual mutation
Showing 1 - 25 of 5,323
HIV-1 Infection Trial in Caba, Rosario (Dolutegravir plus lamivudine)
Withdrawn
- HIV-1 Infection
- Dolutegravir plus lamivudine
-
Caba, Buenos Aires, Argentina
- +1 more
Apr 5, 2022
PIK3CA Mutation-Related Tumors Trial in Shanghai (WX390)
Completed
- PIK3CA Mutation-Related Tumors
-
Shanghai, Shanghai, ChinaShanghai East Hospital
Nov 9, 2023
Advanced Non Small Cell Lung Cancer Trial in Changsha (Toripalimab combination with platinum-containing dual-drug chemo)
Recruiting
- Advanced Non Small Cell Lung Cancer
- Toripalimab combination with platinum-containing dual-drug chemotherapy
-
Changsha, Hunan, ChinaHunan Provincal Tumor Hospital
Dec 28, 2021
Ovarian Cancer Trial in Worldwide (VS-6766, VS-6766 and Defactinib)
Recruiting
- Low Grade Ovarian Serous Adenocarcinoma
- Ovarian Cancer
- avutometinib (VS-6766)
- avutometinib (VS-6766) and Defactinib
-
Scottsdale, Arizona
- +46 more
Dec 29, 2022
Non Small Cell Lung Cancer, KRAS Activating Mutation Trial in Worldwide (VS-6766, VS-6766 and Defactinib)
Recruiting
- Non Small Cell Lung Cancer
- KRAS Activating Mutation
- avutometinib (VS-6766)
- avutometinib (VS-6766) and Defactinib
-
Duarte, California
- +44 more
Dec 22, 2022
Ischemic Stroke, Transient Ischemic Attack Trial in Singapore (Genetic testing)
Not yet recruiting
- Ischemic Stroke
- Transient Ischemic Attack
- Genetic testing
-
Singapore, SingaporeSingapore General Hospital
Mar 9, 2023
HER2, Colorectal Cancer Trial (Disitamab Vedotin Combined With Fruquintinib)
Not yet recruiting
- HER2
- Colorectal Cancer
- Disitamab Vedotin Combined With Fruquintinib
- (no location specified)
Dec 21, 2022
Single Photon Emission Computed Tomography/Computed Tomography
Not yet recruiting
- Brain Glioma
- SPECT with pentavalent 99mTc DMSA
- (no location specified)
Oct 23, 2022
Merkel Cell Carcinoma Trial in Wollstonecraft (Nivolumab 240 mg / Relatlimab 80 mg in a fixed dose combination)
Not yet recruiting
- Merkel Cell Carcinoma
- Nivolumab 240 mg / Relatlimab 80 mg in a fixed dose combination
-
Wollstonecraft, New South Wales, AustraliaMelanoma Institute Australia
Nov 21, 2023
NSCLC, EGF-R Positive NSCLC Trial in Wuxi (Parimparib, Chemotherapy drug, Targeted Therapy Agent)
Recruiting
- Carcinoma, Non-Small-Cell Lung
- EGF-R Positive Non-Small Cell Lung Cancer
- Parimparib
- +2 more
-
Wuxi, Jiangsu, ChinaAffiliated Hospital of Jiangnan University
Jan 30, 2023
Recurrent and Metastatic CRC After Surgery by Multi-omics
Not yet recruiting
- Colorectal Cancer Metastatic
- no intervention
- (no location specified)
Aug 11, 2022
Familial Mediterranean Fever Trial in Thessaloníki
Recruiting
- Familial Mediterranean Fever
-
Thessaloníki, Municipality Of Pavlou Mela, GreecePapageorgiou General Hospital
Sep 11, 2023
Solid Tumors Harboring a BRAF V600 Mutation Trial in Worldwide (LGX818, MEK162, LEE011)
Active, not recruiting
- Solid Tumors Harboring a BRAF V600 Mutation
- LGX818
- +2 more
-
Tampa, Florida
- +22 more
Mar 16, 2022
Inherited Bone Marrow Failure Syndrome, Familial Platelet Disorder With Predisposition to Myeloid Malignancies Trial run by the
Not yet recruiting
- Inherited Bone Marrow Failure Syndrome
- Familial Platelet Disorder With Predisposition to Myeloid Malignancies
- imatinib
- TruSight Oncology
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Oct 20, 2023
Isocitrate Dehydrogenase Gene Mutation Trial in Spain, United States (HMPL-306)
Recruiting
- Isocitrate Dehydrogenase Gene Mutation
-
Santa Monica, California
- +8 more
Feb 22, 2022
Non Small Cell Lung Cancer Metastatic Trial in Worldwide (Osimertinib, Bevacizumab)
Active, not recruiting
- Non Small Cell Lung Cancer Metastatic
-
Dublin, Ireland
- +24 more
Aug 23, 2022
Natural History of Pompe Disease
Recruiting
- Glycogen Storage Disease Type II, Adult
-
Garches, Hauts-de-Seine, FranceHôpital Raymond Poincaré
Apr 20, 2022
Malaria, Anemia Trial in Cove (Bed nets)
Active, not recruiting
- Malaria
- Anemia
- Bed nets
-
Cove, BeninManfred Accrombessi
Aug 23, 2022
Mitochondrial Dysfunctions Driving Insulin Resistance
Recruiting
- Mitochondrial Myopathies
- +2 more
-
Copenhagen, DenmarkRigshospitalet
Oct 16, 2023
Non Small Cell Lung Cancer Trial (Toripalimab, Toripalimab mimetic ())
Not yet recruiting
- Non Small Cell Lung Cancer
- Toripalimab
- Toripalimab mimetic (placebo)
- (no location specified)
Feb 23, 2021
Advanced Breast Cancer, HER2/Neu Negative, Triple-Negative Breast Cancer Trial in Stanford (Talazoparib Tosylate)
Active, not recruiting
- Advanced Breast Cancer
- +2 more
- Talazoparib Tosylate
-
Stanford, CaliforniaStanford University Hospitals and Clinics
Nov 16, 2022
Prevention of Chemo-induced Myelosuppression Trial in Worldwide (ALRN-6924, TAC (doxorubicin 50 mg/m2; cyclophosphamide 500
Recruiting
- Prevention of Chemotherapy-induced Myelosuppression
- ALRN-6924
- TAC (doxorubicin 50 mg/m2; cyclophosphamide 500 mg/m2; docetaxel 75 mg/m2)
-
Tamarac, Florida
- +14 more
Jan 31, 2023